Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Lactobacillus rhamnosus GG
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
This study will look at the effect of taking a probiotic on gastrointestinal and lung symptoms. One group of children with CF will take a probiotic and another a placebo. Comparisons will be made on the bacteria found in stools, number of lung infections, and number of hospitalization and abdominal pain episodes.
2 Years - 16 Years
>= 50 Percent Predicted
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.